Venous thromboembolism after total hip arthroplasty. A review of incidence and prevention during hospitalization and after hospital discharge

Acta Orthopaedica Belgica

Volumn 66, Issue 1, 2000, Pages 1-8

  Haentjens, P ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Deep venous thrombosis; Prevention; Total hip replacement

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PARNAPARIN; TINZAPARIN;

ANTICOAGULANT THERAPY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; HOSPITAL DISCHARGE; HUMAN; MOBILIZATION; PHLEBOGRAPHY; PROPHYLAXIS; REVIEW; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

EID: 0034053939     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Arcelus J. I., Caprini J. A., Traverso C. I.. Venous thromboembolism after hospital discharge. Semin. Thromb. Hemost., 1993, 19, Suppl. 1, 142-146.
2. Bergqvist D., Benoni G., Björgell O., et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N. Engl. J. Med., 1996, 335, 696-700.
3. Bergqvist D., Matzsch T., Jendteg S., Lindgren B., Persson U. The cost-effectiveness of prevention of postoperative thromboembolism. Acta Chir. Scand., 1990, 556, Suppl., 36-41.
4. Beuhler K. O., D'Lima D. D., Colwell C. W. Jr., Otis S. M., Walker R. H. Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening. Clin. Orthop., 1999, 361, 168-177.
5. Beuhler K. O., D'Lima D. D., Petersilge W. J., Colwell C. W. Jr., Walker R. H. Late deep venous thrombosis and delayed weightbearing after total hip arthroplasty. Clin. Orthop., 1999, 361, 123-130.
6. Dahl O. E., Andreassen G., Aspelin T., et al. Prolonged prophylaxis following hip replacement surgery - Results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin. Thromb. Haemost., 1997, 77, 26-31.
7. Grady-Benson J. C., Oishi C. S., Hanson P. B., Colwell C. W. Jr., Otis S. M., Walker R. H., Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty. J. Bone Joint Surg. Am., 1994, 76, 1649-1657.
8. Grady-Benson J. C., Oishi C. S., Hanson P. B., Colwell C. W. Jr., Otis S. M., Walker R. H. Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis. A survey of 110 total hip arthroplasties. Clin. Orthop., 1994, 307, 130-141.
9. Haentjens P. on behalf of the Belgian Nadroparin Post-Hospital Discharge in Orthopedics Study Group (NPHDO). Post-hospital discharge prevention of deep vein thrombosis with nadroparin calcium after elective total hip replacement. Haemostasis, 1998, 28, Suppl. 2, 292.
10. Hirsh J. Evidence for the needs of out-of-hospital thrombosis prophylaxis. Introduction. Chest, 1998, 114, 113S-114S.
11. Hull R. D., Hirsch J., Sackett D. L., Stoddart G. L. Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can. Med. Assoc. J., 1982, 127, 990-995.
12. Imperiale T. F., Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total nip replacement. J. Am. Med. Assn., 1994, 271, 1780-1785.
13. Kudsk K. A., Fabian T. C., Baum S., Gold R. E., Mangiante E., Voeller G. Silent deep vein thrombosis in immobilized multiple trauma patients. Am. J. Surg., 1989, 158, 515-519.
14. Lassen M. R., Bonis L. C., Anderson B. S., et al. Efficacy and safety of prolonged prophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty -the Danish Prolonged Prophylaxis (DaPP) Study. Thromb. Res., 1998, 89, 281-287.
15. Leizorovicz A., Haugh M. C. A meta-analysis of clinical trials of low-molecular-weight heparin in surgical patients. Proc. Third Int. Symp. on Recent Advances in Anti-Thrombotic Therapy, eds : Turpie A. G. G., Büller H. R. ADIS International, Chester, 1994, pp. 37-50.
16. Maloney W. J., Harris W. H., Woolson S. T., Schutzer S. The safety of discontinuing prophylaxis for venous thromboembolic disease based on a negative B-mode ultrasound. Orthop. Transact., 1995, 95, 307.
17. Paiement G. D., Wessinger S. J., Harris W. H. Cost-effectiveness of prophylaxis in total hip replacement. Am. J. Surg., 1991, 161, 519-524.
18. Paiement G. D., Wessinger S. J., Hughes R., Harris W. H. Routine use of adjusted low-dose warfarin to prevent veinous thromboembolism after total hip replacement.. J. Bone Joint Surg., 1993, 75-A, 893-898.
19. Parker M. J., Palmer C. R. A new mobility score for predicting mortality after hip fracture. J. Bone Joint Surg., 1993, 75-B, 797-798.
20. Planes A., Vochelle N., Darmon J. Y., et al. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement : A prospective randomised double-blind placebo-controlled trial. Lancet, 1996, 348, 224-228.
21. Ricotta S., Iorio A., Parise P., Nenci G. G., Agnelli G. Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography - An overview analysis. Thromb. Haemost., 1996, 76, 887-892.
22. Robinson K. S., Anderson D. R., Gross M., Petrie D., Leighton R., Stanish W., Alexander D., Mitchell M., Flemming B., and Gent M. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty : The Post-Arthroplasty Screening Study : A randomized, controlled trial. Ann. Int. Med., 1997, 127, 439-445.
23. Salzman E. W., Davies G. C. Prophylaxis of venous thromboembolism : Analysis of cost effectiveness. Ann. Surg., 1980, 191, 207-218.
24. Serafini S., Beltrametti C., Siragusa S., Alii H. C. Post-thrombotic syndrome after asymptomatic postoperative deep vein thrombosis ; An inception cohort study. Thromb. Haemost., 1997, 718.
25. Trowbridge A., Boese C. K., Woodruff B., Brindley H. H. Sr., Lowry W. E., Spiro T. E. . Incidence of post-hospitalization proximal deep venous thrombosis after total hip arthroplasty. A pilot study. Clin. Orthop., 1994, 299, 203-208.
26. Warwick D., Harrison J., Glew D., Mitchelmore A., Peters T. J., Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep venous thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg., 1998, 79-A, 1158-1166.
27. Weitz J. I. Drug therapy : Low-molecular-weight heparins. New Engl. J. Med., 1997, 337, 688-698.
28. White R. H., Romano P. S., Zhou H., Rodrigo J., Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch. Intern. Med., 1998, 158, 1525-1531.
29. Woolson S. T. Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement. J. Bone Joint Surg., 1996, 78-A, 1735-1740.